Genetic testing to guide treatment for advanced cancers
Part of Cancer, Digestive system, Skin clinical trials.
This study uses genetic testing of your tumor to find specific mutations and match you with targeted therapies, aiming to improve outcomes for advanced cancers with poor prognosis. If you have pancreatic, liver, or triple negative breast cancer and are starting treatment, this trial may help you access personalized treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced cancer (unresectable or metastatic) that is one of these types: pancreatic adenocarcinoma, hepatocellular carcinoma (liver cancer), or triple negative breast cancer.
- You are either newly diagnosed or within your first line of treatment for the advanced cancer.
- You are in good general health (able to care for yourself and are up and about) and can still receive cancer treatment.
- You have a biopsy from a metastatic site or a surgical specimen that can be used for genetic testing.
- You have health coverage through a social security scheme.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genes in your cancer to find a treatment that might work better for you. It tests your tumor sample to match you with a drug that targets your cancer's specific weaknesses.
This study looks at whether using a detailed genetic test of your tumor can help pick the best first or second treatment for advanced lung, colon, breast, or bladder cancer. The goal is to see if this personalized approach helps people live longer.
This trial uses advanced genetic testing on your tumor sample and lab-grown tumor 'organoids' to help pick treatments that may work better for your metastatic pancreatic cancer. The goal is to find a more personalized treatment plan for you.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This trial investigates genetic testing (mutational profiling) in people with various advanced cancers. It aims to understand how these tests can guide more personalized treatment decisions.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.